Essential Tremors: A Literature Review of Current Therapeutics.
Authors: Patel MD, Patel M, Jani R, Patel KG, Patel P, Gandhi SK
Essential tremors (ETs) commonly manifest as involuntary shaking of the hands that disrupt daily activities. These tremors involve the central motor network of the cerebellum, thalamus, and cortical networks, leading to different clinical phenotypes. The goal of this review was to establish evidence-based recommendations for effective care and simplify decisions for those dealing with ET. For this narrative literature review, we conducted a thorough search using core keywords such as "essential tremor" and "therapy." From the 27 selected articles, relevant data were presented regarding pathophysiology, medications, and other treatment options, with necessary supplemental data such as side effects and use cases. This paper examines treatments for ET, including commonly prescribed medications such as propranolol and primidone; invasive treatments such as deep brain stimulation, focused ultrasound thalamotomy, transcranial magnetic stimulation, and some surgical methods; and non-invasive methods such as the neuromodulation technique of transcutaneous afferent patterned stimulation. Overall, this study presents a synthesized understanding of the currently available modalities for managing ETs. It is intended to guide care providers in choosing the best possible method to contain symptoms.
Introduction
Purpose
Other
Study Objective
To review and synthesize existing therapeutic options for essential tremor and provide evidence-based recommendations to guide clinical management.
Disease model
Essential tremor
Targeted brain region(s)
Thalamus
Cargo name and characteristics
Propranolol — small molecule, nonselective beta-adrenergic receptor blocker; Primidone — small molecule, anticonvulsant/barbiturate derivative (metabolized to phenobarbital)
Outcomes and Safety
Summary of Outcomes
Pharmacotherapy (propranolol and primidone as first-line; topiramate as an alternative) reduces essential tremor severity, with botulinum toxin providing short-term focal relief and invasive procedures (focused ultrasound thalamotomy, radiofrequency ablation, and DBS) producing additional tremor reduction at the cost of increased surgical/neurological risk, while noninvasive peripheral nerve stimulation appears as a safer alternative. The review does not report specific focused ultrasound parameters or identify particular parameter settings as successful.
Safety-related matter
The paper states that invasive interventions (focused ultrasound thalamotomy, radiofrequency ablation, DBS) carry increased risk of surgical and neurological adverse effects, while non‑invasive methods (e.g., peripheral nerve stimulation) have greater safety and reduced risk of adverse effects. It also notes pharmacotherapies have associated side effects (reported in supplemental data) and that long‑term safety/efficacy evidence is lacking.
Brain Region
Ultrasound Parameters
Focal Characteristics
Focal depth: None; Focal length: None; Aperture size: None
We are open to feedback. If you see a mistake or have a suggestion, please contact us.
← Back to Search